Randomized controlled trial to determine the efficacy and safety of daikenchuto for abdominal pain and bloating sensation of IBS
- Conditions
- Irritable bowel syndrome
- Registration Number
- JPRN-UMIN000001797
- Lead Sponsor
- TJ-100 IBS study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Not provided
1) Patients who have bowel move disturbance by organic lesion such as IBD(UC and crohn disease etc.) and cancer. 2) Patients suspected of obstruction in stomach and intestines, and with a history of total gastric resection or bowel resection but not apendicitis 3) Patients with hypercalcemia, calculus in the kidney and dysfunction of kidneys. 4) Patients who are taking cardiac glycoside and tetracyclines antibiotics. 5) Patients who took antibiotics at least 2 month prior to observation period 6) Patients with serious complications (liver, kidney, heart, lung, circulatory, or metabolic disorder) 7) Patients with a history of drug allergy 8) Patients who are nursing, pregnant or considering conception 9) Patients who are taking Kampo medicine. 10) Others, including patients who are unfit for the study as determined by the research director or others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IBS-QOL-J
- Secondary Outcome Measures
Name Time Method